Ketorolac Trometamol Brown & Burk Uk

Ketorolac Trometamol, the active ingredient in Ketorolac Trometamol Brown & Burk Uk, is a non‑steroidal anti‑inflammatory drug presented as an ophthalmic solution for ocular use. It treats post‑operative inflammation and pain following eye surgery and other ocular inflammatory conditions.

GNH USA supplies Ketorolac Trometamol Brown & Burk Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ketorolac Trometamol is an ophthalmic NSAID used to control inflammation and pain in the eye. - Post‑operative ocular inflammation: reduces swelling and discomfort after eye surgery. - Post‑operative ocular pain: provides analgesia following ocular procedures. - General ocular inflammation: helps control inflammatory response in various eye conditions.

Ketorolac Trometamol may cause local ocular reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Transient eye redness. - Tearing or watery eyes. - Blurred vision.

Serious or Rare Side Effects: - Severe allergic reaction such as swelling or rash. - Corneal ulceration or perforation. - Significant increase in intra‑ocular pressure.

Ketorolac Trometamol should be used with attention to patient history and ocular condition. - Assess patient history: check for NSAID hypersensitivity. - Avoid use in active ocular infection unless directed. - Use with caution in patients with glaucoma or elevated intra‑ocular pressure. - Monitor for systemic NSAID effects in patients with cardiovascular disease. - Avoid concurrent use with other ophthalmic NSAIDs unless advised. - Store at room temperature: keep in the original container, protect from light and moisture.

Ketorolac Trometamol can interact with systemic and ocular medications.

Major Interactions (Avoid): - Concurrent systemic NSAIDs: increased risk of systemic adverse effects. - Topical corticosteroids: may reduce anti‑inflammatory efficacy.

Moderate Interactions (Monitor Closely): - Anticoagulants: potential for increased bleeding risk. - Beta‑blocker eye drops: possible additive ocular hypotensive effect. - Other ocular medications: assess for compatibility.